10 Best Pharma Stocks to Buy for Long Term Growth
With big American pharmaceutical corporations always searching for medications in China, the US pharmaceutical industry is going through a unique trend never seen before.
Supernus Pharmaceuticals Inc. (SUPN)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Leucadia National Ian Cumming And Joseph Steinberg | 81,313 | $2,663,001 | +231% | 0.02% |
| 2. | Royce & Associates Chuck Royce | 24,582 | $805,061 | +90% | 0.01% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $26.39 | 7,200 | Officer, Director | 465,141 | 2019-08-23 | Filing | |
| $5.65 | 15,000 | Director | 25,000 | 2013-03-22 | Filing | |
| $5.26 | 10,000 | Director | 10,000 | 2013-03-20 | Filing | |
| $5.20 | 5,000 | Director | 5,000 | 2013-03-20 | Filing | |
| $5.17 | 5,000 | Director | 5,000 | 2013-03-20 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $39.15 | 927 | Officer | 7,853 | 2025-02-21 | Filing | |
| $39.70 | 9,477 | Officer | 10,149 | 2025-02-04 | Filing | |
| $39.62 | 700 | Officer | 10,149 | 2025-01-28 | Filing | |
| $39.62 | 2,573 | Officer | 10,149 | 2025-01-27 | Filing | |
| $36.68 | 12,745 | Officer | 9,679 | 2024-12-03 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 9,684,552 | $317,169,082 | 0.01% | |
| 2. | 6,163,892 | $201,867,464 | 0% | |
| 3. | 1,738,482 | $56,935,286 | 0.82% | |
| 4. | 824,155 | $26,991,076 | 0% | |
| 5. | 746,149 | $24,436,380 | 0% |
News See All
10 Cash-Rich Small Cap Stocks To Invest In According To Analysts
Small-cap stocks in the US have been under pressure, with the Russell small cap index falling 10% from its November highs as of January 2025.
12 Best Small Cap Pharma Stocks to Buy Now
Emily Field, Head of European Pharma Research at Barclays, spoke on CNBC on February 20 about the performance of obesity medications, the effects of US tariffs, and the dynamics of the pharmaceutical ...
Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Q4 2024 Earnings Call Transcript
Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Q4 2024 Earnings Call Transcript February 25, 2025Supernus Pharmaceuticals, Inc. beats earnings expectations.
Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Q3 2024 Earnings Call Transcript
Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Q3 2024 Earnings Call Transcript November 4, 2024Supernus Pharmaceuticals, Inc. beats earnings expectations.
Supernus Pharmaceuticals (SUPN) Slid on Disappointing Progress Report on a Key Drug
Scout Investments, Inc, an affiliate of Carillon Tower Advisers, released the “Carillon Scout Small Cap Fund” second quarter 2024 investor letter. A copy of the letter can be downloaded here.
Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Q2 2024 Earnings Call Transcript
Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Q2 2024 Earnings Call Transcript August 6, 2024Supernus Pharmaceuticals, Inc. misses on earnings expectations.
Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Q1 2024 Earnings Call Transcript
Operator: Good afternoon, and welcome to the Supernus Pharmaceuticals First Quarter 2024 Financial Results Conference Call. At this time, all participants are in a listen-only mode.
Corporate Insiders Are Selling These 10 Small-Cap Stocks
In this article, we will take a detailed look at Corporate Insiders Are Selling These 10 Small-Cap Stocks. For a quick overview of such stocks, read our article Corporate Insiders Are Selling These...
11 Best Small Cap Pharma Stocks to Invest In
In this piece, we will take a look at the 11 best small cap pharma stocks to invest in.